Psychopharmacology SCIE

国际简称：PSYCHOPHARMACOLOGY 参考译名：精神药理学

主要研究方向：医学-精神病学非预警期刊审稿周期：较快,2-4周

《精神药理学》(Psychopharmacology)是一本由Springer Berlin Heidelberg出版的以医学-精神病学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q2 JCR分区
201 年发文量
3.5 IF影响因子
未开放 是否OA
181 H-index
1959 创刊年份
Semimonthly 出版周期
English 出版语言

Official Journal of the European Behavioural Pharmacology Society (EBPS)

Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields:

Human Psychopharmacology: Experimental

This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered.

Human Psychopharmacology: Clinical and Translational

This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects.

Preclinical psychopharmacology: Behavioral and Neural

This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels.

Preclinical Psychopharmacology: Translational

This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways.

Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic

This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.

[ 查看全部 ]

投稿咨询加急咨询

Psychopharmacology期刊信息

ISSN：0033-3158
出版语言：English
是否OA：未开放
E-ISSN：1432-2072
出版地区：GERMANY
是否预警：否
出版商：Springer Berlin Heidelberg
出版周期：Semimonthly
创刊时间：1959
开源占比：0.2166
Gold OA文章占比：29.69%
OA被引用占比：0.3149...
出版国人文章占比：0.07
出版撤稿占比：0
研究类文章占比：91.04%

Psychopharmacology CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

7.1

1.053

0.861

学科类别	分区	排名	百分位
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Pharmacology	Q2	88 / 313	72%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Psychopharmacology中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	NEUROSCIENCES 神经科学 PHARMACOLOGY & PHARMACY 药学 PSYCHIATRY 精神病学	3区 3区 3区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	NEUROSCIENCES 神经科学 PHARMACOLOGY & PHARMACY 药学 PSYCHIATRY 精神病学	3区 3区 3区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	PHARMACOLOGY & PHARMACY 药学 NEUROSCIENCES 神经科学 PSYCHIATRY 精神病学	2区 3区 3区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	NEUROSCIENCES 神经科学 PHARMACOLOGY & PHARMACY 药学 PSYCHIATRY 精神病学	3区 3区 3区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	PHARMACOLOGY & PHARMACY 药学 NEUROSCIENCES 神经科学 PSYCHIATRY 精神病学	2区 3区 3区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	NEUROSCIENCES 神经科学 PHARMACOLOGY & PHARMACY 药学 PSYCHIATRY 精神病学	3区 3区 3区

Psychopharmacology JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：NEUROSCIENCES	SCIE	Q2	109 / 310	65%
学科：PHARMACOLOGY & PHARMACY	SCIE	Q2	100 / 354	71.9%
学科：PSYCHIATRY	SCIE	Q2	75 / 276	73%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：NEUROSCIENCES	SCIE	Q2	109 / 310	65%
学科：PHARMACOLOGY & PHARMACY	SCIE	Q2	97 / 354	72.74%
学科：PSYCHIATRY	SCIE	Q2	85 / 276	69.38%

Psychopharmacology历年数据统计

影响因子

中科院分区

Psychopharmacology中国学者发文选摘

1、Desulfovibrio confers resilience to the comorbidity of pain and anxiety in a mouse model of chronic inflammatory pain
Author: Wu, Zifeng; Liu, Hanyu; Yan, Enshi; Zhang, Xinying; Wang, Yuanyuan; Huang, Chaoli; He, Teng; Miao, Liying; Yang, Ling; Jiang, Riyue; Qi, Changyong; Liu, Cunming; Wang, Di; Yang, Chun

Journal: PSYCHOPHARMACOLOGY. 2023; Vol. 240, Issue 1, pp. 87-100. DOI: 10.1007/s00213-022-06277-4
2、The effects of serotonergic psychedelics in synaptic and intrinsic properties of neurons in layer II/III of the orbitofrontal cortex
Author: Tang, Zi-Hang; Yu, Zhi-Peng; Li, Qiong; Zhang, Xiao-Qin; Muhetaer, Kadeliya; Wang, Zheng-Chun; Xu, Peng; Shen, Hao-Wei

Journal: PSYCHOPHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s00213-023-06366-y
3、The M1 muscarinic acetylcholine receptor regulates the surface expression of the AMPA receptor subunit GluA2 via PICK1
Author: Zhu, Zengyan; Wang, Wenjuan; Gu, Chao; Wang, Mei; Yan, Yinghui

Journal: PSYCHOPHARMACOLOGY. 2023; Vol. 240, Issue 1, pp. 239-248. DOI: 10.1007/s00213-022-06304-4
4、Chronic restraint stress-induced depression-like behavior is mediated by upregulation of melanopsin expression in C57BL/6 mice retina
Author: Fu, Yingmei; Liu, Shanshan; Dong, Yigang; Gan, Yixia; Guo, Xiaoyun; Liu, Hongmei; Xu, Qingqing; Yuan, Ruixue; Ning, Ailing; Hong, Wu; Peng, Yanmin; Yu, Shunying

Journal: PSYCHOPHARMACOLOGY. 2023; Vol. 240, Issue 2, pp. 283-293. DOI: 10.1007/s00213-022-06302-6
5、Melatonin alleviates PTSD-like behaviors and restores serum GABA and cortisol levels in mice
Author: Xu, Zixuan; Li, Wen; Sun, Yixin; Jin, Wen; Yu, Li; Yang, Jingyuan; Wang, Qi

Journal: PSYCHOPHARMACOLOGY. 2023; Vol. 240, Issue 2, pp. 259-269. DOI: 10.1007/s00213-023-06312-y
6、The interaction between first-episode drug-naive schizophrenia and age based on gray matter volume and its molecular analysis: a multimodal magnetic resonance imaging study
Author: Chen, Jingli; Wei, Yarui; Xue, Kangkang; Han, Shaoqiang; Wang, Caihong; Wen, Baohong; Cheng, Jingliang

Journal: PSYCHOPHARMACOLOGY. 2023; Vol. 240, Issue 4, pp. 813-826. DOI: 10.1007/s00213-023-06323-9
7、Inhibition of mGluR5 alters BDNF/TrkB and GLT-1 expression in the prefrontal cortex and hippocampus and ameliorates PTSD-like behavior in rats
Author: Cheng, Shuyue; Xu, Jingjing; Wang, Wei; Wang, Rui; Li, Haonan; Jiang, Zhijun; Liu, Dexiang; Pan, Fang

Journal: PSYCHOPHARMACOLOGY. 2023; Vol. 240, Issue 4, pp. 837-851. DOI: 10.1007/s00213-023-06325-7
8、Flupirtine and antihistamines exert synergistic anti-nociceptive effects in mice
Author: Chen, Yanming; Xiao, Xinyi; Huang, Chaonan; Zhu, Jin; Zhou, Huiling; Qin, Huimin; Bao, Yu; Zhuang, Tao; Zhang, Guisen

Journal: PSYCHOPHARMACOLOGY. 2023; Vol. 240, Issue 4, pp. 881-897. DOI: 10.1007/s00213-023-06329-3